Brent Egan to Amides
This is a "connection" page, showing publications Brent Egan has written about Amides.
Connection Strength
0.158
-
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
Score: 0.087
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
Score: 0.072